Prospective study of a new serological test (ASSURE™ TB Rapid Test) for the diagnosis of pulmonary tuberculosis
DESIGN: All consecutive in-patients aged ≥18 years suspected of having active PTB and admitted between June 2001 and March 2003 were tested with three sputum samples for smear and culture of Mycobacterium tuberculosis and serology (done within 3 days).
RESULTS: Of 238 patients initially enrolled (male: female 2.5:1, mean age 56.6 years), the final analysis included 216 patients. For the final diagnosis of PTB, the sensitivity and specificity of the serological test were respectively 60.2% (95%CI 50.5–69.1) and 82.3% (95%CI 74.2–88.2) compared to 53.4% (95%CI 43.8–62.7) and 98.2% (95%CI 93.8–99.5) for the smear test. A combination of smear and serology provided an increased sensitivity of 74.8% (95%CI 65.6–82.2), but a lower specificity of 80.5% (95%CI 72.3–86.8).
CONCLUSION: The new serological test showed a moderate increase in sensitivity but a decrease in specificity compared to smear examination. The combination (smear + serology) test further increased the sensitivity while maintaining a moderate specificity.
Document Type: Regular Paper
Publication date: 2006-06-01
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.
Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites